Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  BIOLASE Inc    BIOL   US0909111082

BIOLASE INC (BIOL)

8
Delayed Quote. Delayed Nasdaq - 07/02 04:00:00 pm
1.69 USD   -2.87%
06/05 BIOLASE : Comments on Recent Decline in Stock Price
05/18 BIOLASE : Veteran Dental Executive Harold C. Flynn Jr. to Become Pre..
04/30 BIOLASE : reports 1Q loss
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

BIOLASE Inc : BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012

01/22/2013 | 08:44am US/Eastern
BIOLASE Expects to Continue to Generate Positive Cash Flow From Operations for 2013 Overall

IRVINE, CA -- (MARKETWIRE) -- 01/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that based on preliminary unaudited financial results, the Company expects to report that it generated positive cash flow from operations for Q4 2012.

"We are pleased with our preliminary unaudited financial results for Q4 2012. It is rewarding to see that our restructuring efforts over the past two years have enabled us to turn the Company around and that we are making significant progress toward achieving our financial goals," said Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929


distributed by
React to this article
Latest news on BIOLASE INC
07/01 BIOLASE : Patent Issued for Systems and Methods for Disruption of an Eye Lens
06/17 BIOLASE : global leader in dental lasers, features groundbreaking periodontal pr..
06/17 BIOLASE : Comments on Recent Decline in Stock Price
06/05 BIOLASE : Comments on Recent Decline in Stock Price
06/02 BIOLASE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
05/19 BIOLASE : BIOL) Appoints New CEO
05/18 BIOLASE : Change in Directors or Principal Officers, Regulation FD Disclosure, F..
05/18 BIOLASE : Veteran Dental Executive Harold C. Flynn Jr. to Become President and C..
05/18 Veteran Dental Executive Harold C. Flynn Jr. to Become President and CEO of B..
05/14 BIOLASE : Announces Results of Annual Meeting
Advertisement
Chart
Duration : Period :
BIOLASE Inc Technical Analysis Chart | BIOL | US0909111082 | 4-Traders
Income Statement Evolution
More Financials